 potent antagonist leukotrien bronchoconstrict human novel leukotrien receptor antagonist abil bronchoconstrict healthi volunt asthmat subject double-blind placebo-control crossov studi design challeng constant infus placebo activ compound provoc concentr decreas sgaw sgaw mean sem healthi volunt asthmat subject placebo treatment intraven mg bronchoconstrict healthi volunt inhal concentr asthmat subject mg signific rightward shift dose-respons curv mg dose-respons curv right potent antagonist bronchoconstrict normal volunt asthmat patient small signific increas baselin airway calib asthmat patient presenc asthmat airway support role sulfidopeptid leukotrien pathogenesi asthma